Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China’s SFDA Wants to Cut Number of Drug Distribution Companies by 10,000

publication date: Feb 20, 2013
China’s SFDA has announced a set of newly-revised regulations for the country’s drug distributors. These new Good Supply Practices (GSP) for drugs, which comprise 187 articles, will promote higher standards of protection for the country’s drug supply among wholesalers and retailers. An SFDA spokesperson also said the government wants to reduce the number of China’s drug wholesalers from a current 13,000 to just 3,000, a draconian rollup of the country’s highly fragmented distribution system. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital